杨宗逸

【摘 要】目的：分析根除幽门螺杆菌对慢性非萎缩性胃炎治疗的效果。方法：抽取2020年8月至2021年8月在本院就诊的76例慢性非萎缩性胃炎患者，检测患者幽门螺杆菌感染情况，且根据患者病情实施针对性治疗。结果：76例非萎缩性胃炎病人中，有幽门螺杆菌性感染的有42例，占55.3%。无幽门螺杆菌感染的病人34例，病理检查有轻度非典型增生有6例，占17.6%；幽门螺杆菌感染的病人42例，病理检查有轻度非典型增生有30例，占71.4%。在综合治疗的方式下，患者的腹胀、腹痛、恶心及反酸症状快速消失，用药后G-17、PGI指标显著提升，与治疗前指标比较有显著差异（P<0.05）。治疗后患者的病情好转率是97.37%，且用药期间4例出现不良反应，不良反应发生率是5.26%。结论：根除幽门螺杆菌可提升慢性非萎缩性胃炎患者治疗的效果，促进患者胃功能的快速恢复，临床应用安全、有效。

【关键词】根除幽门螺杆菌；慢性非萎缩性胃炎；临床治疗

To analyze and evaluate the efficacy of helicobacter pylori eradication in the treatment of chronic non-atrophic gastritis

Yang Zongyi

Dahua Yao Autonomous County People’s Hospital， Hechi Guangxi 530800， China

【Abstract】Objective： To analyze the effect of helicobacter pylori eradication in the treatment of chronic non-atrophic gastritis. Methods： A total of 76 patients with chronic non-atrophic gastritis who were admitted to our hospital from August 2020 to August 2021 were selected to detect helicobacter pylori infection in the patients， and targeted treatment was carried out according to their conditions. Results： Among 76 cases of non-atrophic gastritis， 42 cases （55.3%） had helicobacter pylori infection. In 34 patients without helicobacter pylori infection， pathological examination showed mild atypical hyperplasia in 6 cases （17.6%）；Among 42 patients with helicobacter pylori infection， 30 （71.4%） had mild atypical hyperplasia. In the comprehensive treatment， abdominal distention， abdominal pain， nausea and acid reflux symptoms disappeared rapidly， and g-17 and PGI indicators were significantly improved after treatment， with significant differences compared with those before treatment（P<0.05）. The improvement rate of the patients after treatment was 97.37%， and 4 cases had adverse reactions during the treatment， and the incidence of adverse reactions was 5.26%. Conclusion： Eradication of helicobacter pylori can improve the treatment effect of patients with chronic non-atrophic gastritis， promote the rapid recovery of gastric function， and clinical application is safe and effective.

【Key？Words】Eradication of Helicobacter pylori； Chronic non-atrophic gastritis； Clinical treatment

慢性非萎缩性胃炎为消化内科常见的疾病类型，患者多具有腹胀腹痛、恶心反酸等临床症状，对其日常饮食及生活质量会产生不同程度影响[1]。在患者症状未得到及时治疗的情况下，可能会发展为胃癌，危及患者的生命安全。常规临床以三联疗法治疗为主，应用奧美拉唑、阿莫西林等药物控制胃酸分泌，控制患者的炎症反应，但是临床应用效果不够理想。根除幽门螺杆菌可改善患者的胃黏膜状态，促进患者胃部功能的快速恢复[2]。为了深入探究三联疗法基础上联合根除幽门螺杆菌治疗的效果，文章抽取2020年8月至2021年8月在本院就诊的76例慢性非萎缩性胃炎患者，根据患者用药的方式与效果讨论，报道如下。……